Ibritumomab tiuxetan Y-90 INJ
Ended Awarded
- Contract number
- N0016813F0708
- Awardee
-
Spectrum Pharmaceuticals, Inc. UEI SC4WFM7J1EJ3
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $22,324
Award facts
- Contract value 100% obligated
- $22,324.01 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Irvine, CA 92618, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Modification | $22,324 | |
| Other Administrative Action | $0 |
Quick answers
Who was awarded contract N0016813F0708?
N0016813F0708 was awarded to Spectrum Pharmaceuticals, Inc. by Bureau of Medicine and Surgery (Department of the Navy) on September 12, 2013.
How much is contract N0016813F0708 worth?
The government has obligated $22,324 on N0016813F0708.
Is contract N0016813F0708 an order under another contract?
Yes. N0016813F0708 is a delivery order under V797P5025B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract N0016813F0708 competed?
The extent of competition for N0016813F0708 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award